Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):281–288. doi: 10.1097/QAI.0000000000000458

Table 1.

Patient Characteristics at the Index Visit

Total Cohort (N=152) Non-obese (N=101) Obese** (N=51) P value
Age, years 49 (22, 69) * 50 (22, 68) 49 (31, 69) 0.82
Gender, Male (%) 129 (85%) 94 (94%) 35 (69%) <0.0001
Education, years 13 (7, 20) 13 (7, 18) 13 (9, 20) 0.43
Ethnicity/Race
White (%) 79 (52%) 53 (52%) 26 (51%) 0.86
Hispanic (%) 22 (14%) 12 (12%) 10 (20%) 0.20
African American (%) 48 (32%) 35 (35%) 13 (25%) 0.25
Comorbid Conditions
Tobacco exposure ever (%) 120 (79%) * 78 (77%) 42 (82%) 0.47
IV drug use ever (%) 38 (25%) 39 (29%) 9 (18%) 0.14
Alcohol exposure 4.0 (2.7, 7.6) 4.0 (2.5, 7.3) 4.2 (2.9, 7.6) 0.67
HCV antibody positive 42 (26%) 28 (26%) 14 (25%) 0.92
Body mass index kg/m2 25.4 (17.3, 41.1) 23.6 (17.3, 31.1) 30.9 (22.0, 41.1) N/A
WC for men, cm 94 (71, 140) 90 (71, 101) 108 (102, 140) N/A
WC for women, cm 94 (75, 133) 78 (75, 85) 96 (88, 133) N/A
Diagnosis of diabetes (%) 15 (10%) 9 (9%) 6 (12%) 0.58
HIV Disease Status
AIDS CDC diagnosis 114 (75%) 78 (77%) 36 (71%) 0.37
Duration of HIV, years 14.9 (1.5, 29.5) 15.5 (2.7, 28.6) 14.5 (1.5, 29.5) 0.43
Current CD43, cells/mm3 549 (65, 3199) 504 (65, 1869) 612 (75, 3199) 0.04
Nadir CD43, cells/mm3 117 (0, 816) 101 (0, 816) 155 (0, 369) 0.57
Plasma VL, c/mL (log10) 1.7 (1.6, 3.0) 1.7 (1.6, 3.0) 1.6 (1.6, 2.6) 0.03
Plasma VL, undetectable 124 (82%) 80 (79%) 44 (86%) 0.29
CSF VL, c/mL (log10) 1.7 (1.6, 3.5) 1.7 (1.6, 3.5) 1.6 (1.6, 2.5) 0.04
CSF VL detectable (%) 10 (7%) 8 (8%) 2 (4%) 0.35
Currently on ARV (%) 151 (99%) 100 (99%) 51 (100%) 0.66
Duration of current ARV mo. 26 (13-42) 26 (15, 42) 26 (12, 42) 0.79
Neurocognitive Impairment
Global deficit score (GDS) 0.21 (0.00, 2.36) 0.14 (0.00, 2.36) 0.29 (0.00, 1.93) 0.04
No. with HAND (%) 43 (28%) 21 (21%) 22 (43%) 0.004
*

Median (first and third quartiles) or frequency (percentage)

**

Waist circumference ≥88cm for women and ≥102cm for men